Shopping Cart (0)
My Account

Your Shopping Cart
Academic Discovery WorkshopAdvances in Plant Genomics - Online EventTranslational Regenerative Medicine Congress 2014ISEV2014 Educational EventBiofluid Biopsies and Companion Diagnostics 201420% Discount OfferePoster Award PrizeBlogs

Cellular Therapy and Cord Blood 2013 Market Report

Publisher: Select Biosciences
Published: February 2013
Pages: 172 pages PowerPoint Main Report Plus Associated Data in Excel File

Price:



This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences.

In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.

We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization.  We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.

Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving.  Our coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood.  Furthermore, given our global footprint, we've been able to compare the EU and US markets side-by-side in this analysis.

Select Biosciences also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union.  Details on the statute as well as implications to companies seeking to navigate this space are provided.

This Report is Written and Delivered to Customers in PowerPoint Format allowing convenient drag-and-drop for business plans, R&D presentations, investor presentations.  Report purchasers receive full commercial rights to use the data and analyses presented in the report for their in-house business activities.

Extensive Market Analyses Presented in this Report:

  • Regenerative Medicine and Stem Cell Research Activity in the US
  • Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
  • Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
  • Breakout of Spending by Product Platforms in Various Spaces
  • Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
  • Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
  • Adult Stem Cell Therapy Quantitative Market Forecast
  • Cellular Therapy Product Pipeline
  • Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
  • HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
  • Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
  • Cost Analyses of HSCTs in the EU vs. US Markets
  • Cord Blood Banking Quantitative Market Metrics
  • Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
  • Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
  • EU and US Cord Blood Transplantation Detailed Cost Breakouts
  • EU ATMP Regulation Detailed Analysis
  • Stem Cells Worldwide Publications Analysis

Report Table of Contents (TOC) [Click Here to Download PDF File]

Sample Pages from the Market Report [Downloadable PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Call for papers - Clinical Applications of Stem Cells 2015
Call for papers - Clinical Applications of Stem Cells 2015
We are now accepting papers for the Clinical Applications of Stem Cells meeting which will take place on the 26-27 of February 2015 in Singapore.


Call for papers - Advances in qPCR and dPCR 2015, Singapore
Call for papers - Advances in qPCR and dPCR 2015, Singapore
We are now accepting papers for the Advances in qPCR and dPCR meeting which will take place on the 21-22 May 2015 in Singapore.


Accreditation
“The Medical Association of Saxony certificates the two-day congress with 16 continuing education points.”


LAB-ON-A-CHIP ASIA - EARLY BIRD
LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$150 - EARLY BIRD DEADLINE 10 OCTOBER 2014. Don't miss out - register today!


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.


Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com